BrainStorm Announces New Survival Data From Expanded Access Program Of NurOwn In ALS; 90% Of Participants Survived More Than Five Yers From Onset Of ALS Symptoms

Key findings include:

• 90% of participants (9/10) survived more than five years from the onset of ALS symptoms, compared to published estimates indicating that approximately 10% of individuals with ALS survive beyond five years. Notably, the single death in the cohort occurred following elective euthanasia.
• The median survival observed in the EAP cohort was 6.8 years (range: 6 to 7 years) from symptom onset.
• Given that approximately 10% of individuals with ALS survive beyond five years[1], the probability of observing such extended survival in 9 out of 10 participants purely by chance is extremely low. This strongly suggests that the survival outcomes in this cohort are unlikely to be the result of random variation alone.